Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

N-(2-Hydroxyethyl)-L-valyl-L-leucine in rat urine as a hydrolytic cleavage product of ethylene oxide adduct with globin

J. Mráz, I. Hanzlíková, I. Linhart, Š. Dušková, L. Dabrowská, K. Hejl,

. 2019 ; 93 (3) : 603-613. [pub] 20190121

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT13401-4/2012 Internal Grant Agency of the Czech Ministry of Health - International
IN 75010330 Ministerstvo ZdravotnictvíCeskéRepubliky (CZ) - International
CZ.1.06/3.2.01/11.08435 European Regional Development Fund - International

E-resources Online Full text

NLK ProQuest Central from 2002-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2002-01-01 to 1 year ago
Public Health Database (ProQuest) from 2002-01-01 to 1 year ago

Ethylene oxide (EO), a genotoxic industrial chemical and sterilant, forms covalent adducts with DNA and also with nucleophilic amino acids in proteins. The adduct with N-terminal valine in globin [N-(2-hydroxyethyl)valine (HEV)] has been used in biomonitoring of cumulative exposures to EO. Here we studied in rats the fate of EO-adducted N-termini of globin after life termination of the erythrocytes. Rat erythrocytes were incubated with EO to produce the HEV levels in globin at 0.4-13.2 µmol/g as determined after acidic hydrolysis. Alternative hydrolysis of the isolated globin with enzyme pronase afforded N-(2-hydroxyethyl)-L-valyl-L-leucine (HEVL) and N-(2-hydroxyethyl)-L-valyl-L-histidine (HEVH), the EO-adducted N-terminal dipeptides of rat globin α- and β-chains, respectively. The ratio of HEVL/HEVH (1:3) reflected higher reactivity of EO with the β-chain. The EO-modified erythrocytes were then given intravenously to the recipient rats. HEVL and HEVH were found to be the ultimate cleavage products excreted in the rat urine. Finally, rats were dosed intraperitoneally with EO, 50 mg/kg. Herein, the initial level of globin-bound HEVL (11.7 ± 1.3 nmol/g) decreased almost linearly over 60 days corresponding to the life span of rat erythrocytes. Daily urinary excretion of HEVL was almost constant for 30-40 days, decreasing faster in the subsequent phase of elimination. Recoveries of the total urinary HEVL from its globin-bound form were 84 ± 6% and 101 ± 17% after administrations of EO and the EO-modified erythrocytes, respectively. In conclusion, urinary HEVL appears to be a promising novel non-invasive biomarker of human exposures to EO.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20022849
003      
CZ-PrNML
005      
20201214124855.0
007      
ta
008      
201125s2019 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00204-019-02388-8 $2 doi
035    __
$a (PubMed)30666356
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Mráz, Jaroslav $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42, Prague, Czech Republic. jaroslav.mraz@szu.cz.
245    10
$a N-(2-Hydroxyethyl)-L-valyl-L-leucine in rat urine as a hydrolytic cleavage product of ethylene oxide adduct with globin / $c J. Mráz, I. Hanzlíková, I. Linhart, Š. Dušková, L. Dabrowská, K. Hejl,
520    9_
$a Ethylene oxide (EO), a genotoxic industrial chemical and sterilant, forms covalent adducts with DNA and also with nucleophilic amino acids in proteins. The adduct with N-terminal valine in globin [N-(2-hydroxyethyl)valine (HEV)] has been used in biomonitoring of cumulative exposures to EO. Here we studied in rats the fate of EO-adducted N-termini of globin after life termination of the erythrocytes. Rat erythrocytes were incubated with EO to produce the HEV levels in globin at 0.4-13.2 µmol/g as determined after acidic hydrolysis. Alternative hydrolysis of the isolated globin with enzyme pronase afforded N-(2-hydroxyethyl)-L-valyl-L-leucine (HEVL) and N-(2-hydroxyethyl)-L-valyl-L-histidine (HEVH), the EO-adducted N-terminal dipeptides of rat globin α- and β-chains, respectively. The ratio of HEVL/HEVH (1:3) reflected higher reactivity of EO with the β-chain. The EO-modified erythrocytes were then given intravenously to the recipient rats. HEVL and HEVH were found to be the ultimate cleavage products excreted in the rat urine. Finally, rats were dosed intraperitoneally with EO, 50 mg/kg. Herein, the initial level of globin-bound HEVL (11.7 ± 1.3 nmol/g) decreased almost linearly over 60 days corresponding to the life span of rat erythrocytes. Daily urinary excretion of HEVL was almost constant for 30-40 days, decreasing faster in the subsequent phase of elimination. Recoveries of the total urinary HEVL from its globin-bound form were 84 ± 6% and 101 ± 17% after administrations of EO and the EO-modified erythrocytes, respectively. In conclusion, urinary HEVL appears to be a promising novel non-invasive biomarker of human exposures to EO.
650    _2
$a zvířata $7 D000818
650    _2
$a biologické markery $x moč $7 D015415
650    _2
$a dipeptidy $x metabolismus $x moč $7 D004151
650    _2
$a monitorování životního prostředí $7 D004784
650    _2
$a erytrocyty $7 D004912
650    _2
$a ethylenoxid $x toxicita $7 D005027
650    _2
$a globiny $x metabolismus $7 D005914
650    _2
$a nebezpečné látky $x toxicita $7 D015386
650    _2
$a hydrolýza $7 D006868
650    _2
$a leucin $7 D007930
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a valin $x chemie $7 D014633
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hanzlíková, Iveta $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42, Prague, Czech Republic.
700    1_
$a Linhart, Igor $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 1905, 166 28, Prague, Czech Republic.
700    1_
$a Dušková, Šárka $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42, Prague, Czech Republic.
700    1_
$a Dabrowská, Ludmila $u Centre of Occupational Health, National Institute of Public Health, Šrobárova 48, 100 42, Prague, Czech Republic.
700    1_
$a Hejl, Kamil $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 1905, 166 28, Prague, Czech Republic.
773    0_
$w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 93, č. 3 (2019), s. 603-613
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30666356 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214124855 $b ABA008
999    __
$a ok $b bmc $g 1595168 $s 1113525
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 93 $c 3 $d 603-613 $e 20190121 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
GRA    __
$a NT13401-4/2012 $p Internal Grant Agency of the Czech Ministry of Health $2 International
GRA    __
$a IN 75010330 $p Ministerstvo ZdravotnictvíCeskéRepubliky (CZ) $2 International
GRA    __
$a CZ.1.06/3.2.01/11.08435 $p European Regional Development Fund $2 International
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...